Jithma P. Abeykoon

Jithma P. Abeykoon, M.D. is an Assistant Professor of Medicine and Oncology at Mayo Clinic College of Medicine and Science, serving as a Senior Associate Consultant in the Division of Hematology within the Department of Internal Medicine. With expertise in lymphomas, histiocytic cancers, and DNA damage repair mechanisms, he bridges basic science, translational research, and clinical trials to develop novel therapies for hematologic malignancies.

• Education: MD from University of Kansas School of Medicine, BS in Biochemistry/Gerontology from Kansas State University, Hematology/Oncology Fellowship at Mayo Clinic
• Research Focus: DNA damage repair pathways in blood cancers, replication stress in lymphoma, Waldenstrom macroglobulinemia biology, and targeted therapies for histiocytic neoplasms
• Clinical Contributions: Pioneered CRM1 inhibitor + salicylate combination therapy, conducted investigator-initiated phase 1 trials for relapsed lymphoma
• Scientific Awards:
  • Merit Award, Conquer Cancer Foundation of ASCO
  • Robert A. Kyle Career Development Award
  • Mayo Brothers Distinguished Fellowship Award
  • Young Investigator Draft Award
  • Alpha Omega Alpha Honor Society
• Publications: Over 80 peer-reviewed works focusing on lymphoma, Waldenstrom macroglobulinemia, histiocytic disorders, and DNA repair mechanisms
• Professional Roles: Co-chair of Mayo-University of Alabama Histiocytosis Working Group, editorial board member for Frontiers in Medicine and Biomolecules